drugset / Trial / NCT02860052
SB208 for the Treatment of Tinea Pedis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a phase 2, multi-center, double-blind, randomized, vehicle-controlled study to be conducted in non immunocompromised adult subjects with interdigital tinea pedis.
Timeline
- Start
- 2016-07-19
- Primary completion
- 2017-01
- Completion
- 2017-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BERDAZIMER SODIUM | Small molecule | 2 % | Topical |
| Subject | BERDAZIMER SODIUM | Small molecule | 4 % | Topical |
| Subject | BERDAZIMER SODIUM | Small molecule | 16 % | Topical |